Related Experiment Video
Updated: Oct 1, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Advances in immunotherapy for cervical cancer: recent developments and future directions
Michael Vincent Sherer1, Nikhil V Kotha1, Casey Williamson1
1Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California, USA.
Novel immunotherapies show promise for treating advanced cervical cancer, particularly human papillomavirus (HPV)-driven types. These treatments activate the immune system to overcome cancer's defenses, offering new hope for patients.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Locally advanced, recurrent, or metastatic cervical cancer lacks effective treatments.
- Human papillomavirus (HPV) drives most cervical cancers, employing immune evasion tactics.
- Existing therapies need improvement for better patient outcomes.
Purpose of the Study:
- To review the immune landscape of cervical cancer.
- To evaluate the clinical data on immunotherapy for cervical cancer.
- To explore potential combination therapies and synergies.
Main Methods:
- Review of clinical data on immunotherapies for cervical cancer.
- Analysis of immune evasion mechanisms in HPV-driven cancers.
- Discussion of emerging therapeutic strategies.
Main Results:
- Immune checkpoint inhibitors show encouraging results, establishing a new standard of care for recurrent/metastatic disease.
- Therapeutic vaccines and engineered T cells are in earlier development stages.
- Synergies between immunotherapy and conventional therapies or radiation show potential.
Conclusions:
- Immunotherapy is an emerging and effective treatment for cervical cancer.
- It is a key component of first-line treatment for recurrent or metastatic disease.
- Immunotherapy may soon be integrated into the definitive management of locally advanced cervical cancer.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Microorganisms in Medicine and Therapeutics
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

